Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 31, 2010 08:00 ET | Source: Tenax Therapeutics, Inc.

Study Shows DERMACYTE(R) Oxygen Concentrate Appears to Improve the Appearance of Fine Lines and the Perception of Skin Appearance

DURHAM, N.C., Aug. 31, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that results from an 8-week cosmetic study showed that the topical...
August 03, 2010 07:50 ET | Source: Tenax Therapeutics, Inc.

Photo Release -- DERMACYTE(R) Oxygen Concentrate Now Available in 10ml Pump Bottles

DURHAM, N.C., Aug. 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company now offers its revolutionary anti-aging,...
August 02, 2010 12:30 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Signs CRADA With U.S. Navy to Study Treatment of Decompression Sickness Using Oxycyte(R) Emulsion

DURHAM, N.C., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has entered into a Cooperative Research and Development Agreement...
July 28, 2010 20:00 ET | Source: Tenax Therapeutics, Inc.

Photo Release -- Oxygen Biotherapeutics Introduces DERMACYTE(R) Oxygenating Eye Complex, an Oxygen-Rich Serum to Reduce the Appearance of Fine Lines Around Eyes

DURHAM, N.C., July 28, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today introduced its new, innovative skin care product, DERMACYTE® Oxygenating...
July 23, 2010 16:38 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Files FY2010 Annual Report on Form 10-K

DURHAM, N.C., July 23, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission (SEC)...
June 30, 2010 11:33 ET | Source: Tenax Therapeutics, Inc.

Oxycyte(R) PFCE Decreases Mortality From Decompression Sickness in Preclinical Study

DURHAM, N.C., June 30, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that results from U.S. Navy studies demonstrated decreased mortality in porcine animal models...
June 28, 2010 07:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics' Common Shares to Begin Trading on the SIX Swiss Exchange June 29, 2010

DURHAM, N.C., June 28, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) announced today that the company's common stock will begin trading on the Swiss SIX Exchange with...
June 25, 2010 07:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Set to Join Russell Microcap Index

DURHAM, N.C., June 25, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) is set to join the Russell Microcap Index when Russell Investments reconstitutes its comprehensive set of...
June 21, 2010 07:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Approval for SIX Swiss Exchange Listing

DURHAM, N.C., June 21, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in...
June 10, 2010 09:29 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Expands Its Dermacyte(R) Skin Care Sales Territories Into Phoenix and Detroit

DURHAM, N.C., June 10, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced it has expanded the sales territory for its Dermacyte® skin care products into two...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right